Camber Capital Management LP Sells 350,000 Shares of Sarepta

Camber Capital Management LP trimmed its position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 46.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 400,000 shares of the biotechnology company’s stock after selling 350,000 shares during the period. […]

Related Keywords

Canada , Wellington , New Zealand General , New Zealand , Richard Barry , Douglass Ingram , Nasdaq , Royal Bank , Sarepta Therapeutics Inc , Exchange Commission , Wellington Management Group , Norges Bank , Boxer Capital , Cantor Fitzgerald , Barclays , York Mellon Corp , Camber Capital Management , Sarepta Therapeutics , Free Report , Capital Management , Management Group , Sigma Advisers , New York Mellon Corp , Director Richard Barry , Get Free Report , Visit Holdingschannel , Sarepta Therapeutics Daily , Nasdaq Srpt , Srpt , Medical , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,